What it is
Researchers systematically deconstructed the tetracyclic ergoline core of LSD to create 9 simplified ergoline analogues (termed ergologs) and evaluated them in pharmacological assays relevant to 5-HT2A, 5-HT2B, and 5-HT2C receptor function. The work revealed the minimal pharmacophore of LSD needed to produce maximal 5-HT2A agonism and hallucinogenic behavioral effects, and established strategies for reducing LSD's hallucinogenic and cardiotoxic potential. Two ergologs, UCD0094 and UCD0076, showed improved safety profiles, and UCD0076 preferentially activated 5-HT2C receptors over other 5-HT2 receptors and produced antipsychotic-like properties in mouse behavioral assays.
Why it matters
LSD's complex chemical architecture has limited efforts to synthesize analogues with better safety and efficacy, so mapping the minimal features responsible for its activity opens a route to designing simpler ergoline compounds. Separating the molecular features that drive hallucinogenic and cardiotoxic effects from those that engage specific serotonin receptors is a concrete step toward psychedelic-derived molecules with reduced liabilities.
Underlined numbers link to their source. Every metric and quoted figure is listed under Sources and data below.
Filed underPsychedelics and Drug Studies, Plant and fungal interactions, Chemical synthesis and alkaloids